师资队伍
当前位置: 学院首页 > 师资队伍 > 医用高分子材料及人工器官系 > 教授-研究员 > 正文

张凌

  • 职 称: 研究员
  • 所属学科: 医用高分子材料
  • 导师情况: 博导
  • E-mail: zhangling83@scu.edu.cn
  • 个人主页:

张凌博士,男,四川大学高分子科学与工程学院研究员,医用高分子材料及人工器官系成员。2018年入职,研究主要涉及高分子与生物学交叉领域,包括材料-生物相互作用机理及后续生物效应、小体积材料的跨膜运输和信号、新型药物传递材料、高分子及纳米材料的毒性研究等等。此外,对生物信息学、计算数学、生物物理等学科在相关研究中得应用也有浓厚兴趣。近年在Current Biology, AFM, JCR, Nano Research, Biomaterial等杂志上发表论文。

个人简介

20189月 至今,四川大学高分子科学与工程学院,特聘副研究员

20113--20186月,英国曼彻斯特大学生物、医药及健康学院,博士后,合作导师:Philip Woodman教授,Victoria Allan教授,Alan Roseman博士。

20069--20113月,英国曼彻斯特大学生命科学院,硕士及博士,导师:Philip Woodman教授,Hilary Ashe博士,Richard Kamerer博士。

20029--20066月,复旦大学生命科学院,学士,导师:金力教授。

研究方向

1. 高分子等材料与生物系统微观相互作用

2. 脂质体及其他纳米材料递送系统

3. 微材料的跨膜运输以及跨膜信号系统

4. 结合组学、数学模型等的生物-纳米系统研究

常年招聘材料、生物、医药、数学、物理背景的研究生(包括各种联合培养形式)和博后,同时欢迎四川大学各学科背景的本科同学,以及成都地区其他院校本科生到实验室做毕业论文或利用业余时间从事科研项目。此外,我们将为课题组成员以后的留学、出国交流及保研等方面尽量提供推荐和帮助。欢迎感兴趣的同学与张老师直接联系。邮箱: zhangling83@scu.edu.cn地址:四川大学望江校区高分子学院附楼306

2018年以来发表文献:

2020

The pore size of mesoporous silica nanoparticles regulates their antigen delivery efficiency. Xiaoyu Hong, Xiaofang Zhong, Guangsheng Du, Yingying Hou, Yunting Zhang, Zhirong Zhang, Tao Gong, Ling Zhang*, Xun Sun*. 2020 Jun 19;6(25):eaaz4462. doi: 10.1126/sciadv.aaz4462

Target delivering paclitaxel by ferritin heavy chain nanocages for glioma treatment. Wei Liu, Qing Lin, Yu Fu, Shiqi Huang, Chengqi Guo, Lin Li, Leilei Wang, Zhirong Zhang, Ling Zhang*. Journal of Controlled Release. 2020 Jul 10;323:191-202. doi: 10.1016/j.jconrel.2019.12.010

Co-delivery of antigen and dual adjuvants by aluminum hydroxide nanoparticles for enhanced immune responses. Yingying Hou, Ying Wang, Yao Tang, Zixuan Zhou, Lu Tan, Tao Gong, Ling Zhang*, Xun Sun*. Journal of Controlled Release. 2020 Oct 10;326:120-130. doi: 10.1016/j.jconrel.2020.06.021

Tailored Elasticity Combined with Biomimetic Surface Promotes Nanoparticle Transcytosis to Overcome Mucosal Epithelial Barrier. Yaxian Zheng, Liyun Xing, Liqiang Chen, Rui Zhou, Jiawei Wu, Xi Zhu, Lian Li, Yucheng Xiang, Ruinan Wu, Ling Zhang*, Yuan Huang*. Biomaterials. 2020 Dec;262:120323. doi: 10.1016/j.biomaterials.2020.120323.

Co-delivery of p38α MAPK and p65 siRNA by novel liposomal glomerulus-targeting nano carriers for effective immunoglobulin a nephropathy treatment. Yuanfang Wang, Qingsi Wu, Jiading Wang, Lin Li, Xun Sun, Zhirong Zhang, Ling Zhang*. Journal of Controlled Release. 2020 Apr 10;320:457-468. doi: 10.1016/j.jconrel.2020.01.024.

Improved melanoma suppression with target-delivered TRAIL and Paclitaxel by a multifunctional nanocarrier. Shiqi Huang, Yicong Zhang, Luyao Wang, Wei Liu, Linyu Xiao, Qing Lin, Tao Gong, Xun Sun, Qin He, Zhirong Zhang, Ling Zhang*. Journal of Controlled Release. 2020 Sep 10;325:10-24. doi: 10.1016/j.jconrel.2020.03.049.

2019

Novel fibronectin-targeted nanodisk drug delivery system displayed superior efficacy against prostate cancer compared with nanospheres. Luyao Wang, Bingjie Zhou, Shiqi Huang, Mengke Qu, Qing Lin, Tao Gong, Yuan Huang, Xun Sun, Qin He, Zhirong Zhang, Ling Zhang*. Nano Research. 2019;12:2451–2459. doi:10.1007/s12274-019-2488-3

Polystyrene nanoparticles reduced ROS and inhibited ferroptosis by triggering lysosome stress and TFEB nucleus translocation in a size-dependent manner. Lin Li, Shili Sun, Lingli Tan, Yuanfang Wang, Luyao Wang, Zhirong Zhang, Ling Zhang*. Nano Letters. 2019 September 26;19(11):7781-7792. doi:10.1021/acs.nanolett.9b02795

Exosome-like nanoplatform modified with targeting ligand improves anti-cancer  and anti-inflammation effects of Imperialine. Qing Lin, Mengke Qu, Hirak K Patra, Shanshan He, Luyao Wang, Xun Hu, Linyu Xiao, Yu Fu, Tao Gong, Qin He, Ling Zhang*, Xun Sun and Zhirong Zhang. Journal of Controlled Release, 2019 October; 311–312:104-116. doi:10.1016/j.jconrel.2019.08.037

Target delivering paclitaxel by ferritin heavy chain nanocages for glioma treatment. Wei Liu, Qing Lin, Yu Fu, Shiqi Huang, Chengqi Guo, Lin Li, Leilei Wang, Zhirong Zhang, Ling Zhang*. Journal of Controlled Release, In Press. doi:10.1016/j.jconrel.2019.12.010

Therapeutic strategies for the costimulatory molecule OX40 in T-cell mediated immunity. Yu Fu, Qing Lin, Zhirong Zhang*, Ling Zhang*. Acta Pharmaceutica Sinica B. 2020 March;10(3):414-433. doi:10.1016/j.apsb.2019.08.010

Mechanistic and therapeutic study of novel anti-tumor function of natural compound imperialine for treating non-small cell lung cancer. Qing Lin, Mengke Qu, Shanshan He, Luyao Wang, Xun Hu, Linyu Xiao, Yu Fu, Tao Gong, Xun Sun, Qin He, Ling Zhang*, Zhirong Zhang. Journal Ethnopharmacology. 2020 Jan 30;247:112283. doi: 10.1016/j.jep.2019.112283

2018

A brain targeting functionalized liposomes of the dopamine derivative N-3,4-bis(pivaloyloxy)-dopamine for treatment of Parkinson's disease. Qu M, Lin Q, He S, Wang L, Fu Y, Zhang Z, Zhang L. J Control Release. 2018 May 10;277:173-182. doi: 10.1016/j.jconrel.2018.03.019.

A novel α-enolase-targeted drug delivery system for high efficacy prostate cancer therapy. Wang L, Qu M, Huang S, Fu Y, Yang L, He S, Li L, Zhang Z, Lin Q, Zhang L. Nanoscale. 2018 Jul 19;10(28):13673-13683. doi: 10.1039/c8nr03297a.

Erythrocyte-membrane-camouflaged nanoplatform for intravenous glucose-responsive insulin delivery. Fu Y, Liu W, Wang L, Zhu B, Qu M, Yang L, Sun X, Gong T, Zhang Z, Lin Q, Zhang L. Adv Functional Materials. 2018 August 26. Doi: 10.1002/adfm.201802250.

Liver-Targeted Co-delivery of Entecavir and Glycyrrhetinic Acid Based on Albumin Nanoparticle To Enhance the Accumulation of Entecavir. He S, Lin Q, Qu M, Wang L, Deng L, Xiao L, Zhang Z, Zhang L. Mol Pharm. 2018 Sep 4;15(9):3953-3961. doi: 10.1021/acs.molpharmaceut.8b00408.

Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease. Qu M, Lin Q, Huang L, Fu Y, Wang L, He S, Fu Y, Yang S, Zhang Z, Sun X, Zhang L. J Control Release. 2018 October 10;287:156-166. Doi: 10.1016/j.jconrel.2018.08.035.

 

 


 


 

 

                                              

 

 

 

 

 

关闭